Phase 3 study for people with Obesity

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 15 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor AstraZeneca
Registry number NCT07667803
Started 29 June 2026 Today 16 October 2026 Estimated completion 31 July 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Research Site Botany NSW Recruiting
Research Site Camberwell VIC Recruiting
Research Site Charlestown NSW Recruiting
Research Site Maroubra NSW Recruiting
Research Site St Albans VIC Recruiting
Research Site St Leonards NSW Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 4500

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria

* Legal age of consent and at least 18 years old

* Study 1 -

* BMI ≥ 30 kg/m2 or

* 25 kg/m2 ≤ BMI \< 30 kg/m2 with at least one of the following weight-related comorbidities:

* Hypertension

* Prediabetes

* Dyslipidemia

* Cardiovascular disease

* Obstructive sleep apnea.

* Study 2 - BMI ≥ 25 kg/m2 and T2DM defined as below:

* Established diagnosis of T2DM

* Without established diagnosis of T2DM and HbA1c ≥ 6.5% (48 mmol/mol) at the screening visit

* Stable body weight (self-reported or documented) for 90 days prior to the screening visit (± 5% body weight change)

* History of at least one self-reported unsuccessful dietary effort to lose body weight.

Exclusion Criteria

* Study 1 - Established diagnosis of T1DM or T2DM.

* Study 2 - Any of the following medical history, laboratory values, or complications related to diabetes:

* T1DM

* HbA1c ≥ 10% (86 mmol/mol) at the screening visit

* Currently receiving, or anticipated to receive, therapeutic intervention for diabetic retinopathy and/or macular edema.

* Have had more than one episode of severe hypoglycemia within 180 days prior to the screening visit, or has a history of hypoglycemia unawareness or poor recognition of hypoglycemic symptoms

* History of acute (unless due to previously resolved gallstone pancreatitis and post-cholecystectomy) or chronic pancreatitis

* History/family history (first degree biologic relatives) of medullary thyroid cancer or multiple endocrine neoplasia type 2

Dates on the record

Started 29 June 2026
Estimated completion 31 July 2028
Registry last updated 13 October 2026
Checked by Voxsanity 15 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 13 October 2026.
  • This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.